CD45 depleted CTC-enriched fractions expressing CXCR4, and the alpha-chemokine receptor specific for stromal-derived-factor-1, isolated from the PB of prostate cancer patients through the CellSearch® platform, documented poor prognosis in patients treated by radiotherapy [101]. Here, CXCR4 is linked to prostate cancer.